The nth paradox in Q3 figures
2015 Q3 revenues grew up 11% to TND9.7M, pulled up by officinal sales increasing from TND3.5M in Q3 2014 to TND4.3M in Q3 2015, i.e. 23% rise. Since early this year, sales have increased by 8%, from TND28.3M in September, 2014, to TND30.5M by the end of September, 2015. Hospitals offered the highest contribution to sales with revenues growing from TND14.8M in 2014 to TND16.3M in 2015. Exports stood at a modest level with revenues worth TND229.4K in Q3 and TND2M in the nine first months.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.